For decades, the healthcare industry has lacked a long list of elements necessary to understand the nature of hundreds of rare diseases — industry cohesiveness and data transparency chief amongst them. With the help of PwC and Microsoft, one pioneering group of minds may have finally found a key part of the solution: an open-source approach to medical research.
Get the latest OSIC news delivered right to your inbox
No spam. Just news.